Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”
In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires
PCI Files Application For Research Base COP
Eight applications Received For NSABP chairman
Pitt Criticizes NCI Stance On Repayment For Fraud Trials
Broder, Herberman, Decline To Coauthor Reanalysis of Data
“I Can’t Permit Destruction of NSABP,” Fisher Writes
Herberman: Progress Made To Stabilize NSABP
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- Harvey Risch, critic of COVID-19 response, tapped by White House to serve as chair of the President’s Cancer Panel
- Brown University reaches agreement with Trump administration to restore funding
- Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- John Byrd brings blood cancer expertise to solid tumor, immunology powerhouse at UPMC









